Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. Companies
  3. clinical phase
Show results for
Products
Services
Software
Applications

Companies

News
Articles
Downloads
Videos

Refine by
Locations

  • USA
  • Canada
  • Europe

  • Africa
  • Asia & Middle East
  • Australasia
  • Latin America
  • North America
Business Types

  • Manufacturer
  • Technology
  • Service provider
  • Software vendor
  • Laboratory
  • Market research company
  • Consulting firm
  • Custom manufacturer
Industries served

  • Medical / Health Care
  • Chemical & Pharmaceuticals
  • Monitoring and Testing
  • Health and Safety
  • Manufacturing, Other
  • Automobile & Ground Transport
  • Defense
  • Electronics and Computers
  • Aerospace & Air Transport
  • Waste and Recycling
  • Oil, Gas & Refineries
  • Environmental
  • Air and Climate
  • University / Academia / Research
  • Government
  • Food and Beverage
  • Energy
Employees

  • 1-10
  • 11-100
  • 101-1000
  • Over 1000

Clinical Phase Suppliers & Manufacturers

196 companies found

Ascelia Pharma AB

Ascelia Pharma AB

based inMalmö, SWEDEN
Ascelia Pharma is a biotech company focused on orphan oncology treatments. We develop and commercialize novel drugs that address unmet medical needs and have a clear development and market pathway. Oncoral is a novel oral irinotecan tablet in ...
Oncoral - Novel Daily Irinotecan Chemotherapy Agent

Oncoral - Novel Daily Irinotecan Chemotherapy Agent

Oncoral is a daily irinotecan tablet with the potential to offer better patient outcomes with improved safety following the daily dosing at home compared to intravenous high-dose infusions at the hospital. Following successful Phase ...
CONTACT SUPPLIER

Diamyd Medical AB

Diamyd Medical AB

based inStockholm, SWEDEN
Diamyd Medical is a clinical-stage diabetes company active in the field of pharmaceutical development. We develop two novel disease-modifying drugs: the antigenspecific immunotherapy Diamyd and the oral regenerative and immunomodulatory therapeutic ...
Remygen - Controlled Release Tablet

Remygen - Controlled Release Tablet

Remygen® is a controlled release tablet consisting of the active pharmaceutical ingredient GABA. The GABA substance is chemically synthesized in a well-controlled GMP process together with a global contract manufacturer. The manufacturing ...
CONTACT SUPPLIER

CervoMed

CervoMed

based inBoston, MASSACHUSETTS (USA)
CervoMed is a clinical stage company dedicated to the development and commercialization of drug treatments for neurodegenerative diseases with a focus on the early stages of the neurodegenerative process. Until August 2023, CervoMed was known as ...
CONTACT SUPPLIER

STALICLA

STALICLA

based inGeneve, SWITZERLAND
STALICLA has developed the first neurodevelopmental disorder-specific precision medicine discovery platform with an initial application in autism spectrum disorder (ASD). Until now, patient diagnosis and drug development for ASD and other NDDs have ...
STALICLA - Databased Endophenotyping Patient Identification (DEPI) Technology

STALICLA - Databased Endophenotyping Patient Identification (DEPI) Technology

STALICLA’s precision medicine approach begins with ‘endophenotyping’-identifying the nonbehavioral physical and molecular presentations of NDDs and characterizing subgroups of patients with similar disease signatures. DEPI matches ...
CONTACT SUPPLIER

Ergomed

Ergomed

based inSurrey, UNITED KINGDOM
Ergomed is focused on providing specialised services to the biopharmaceutical industry. Ergomed is a global provider of expert, high-quality services to the biopharmaceutical industry, spanning all phases of clinical trials, post-approval ...
CONTACT SUPPLIER

Galera Therapeutics, Inc.

Galera Therapeutics, Inc.

based inMalvern, PENNSYLVANIA (USA)
We are a clinical stage biopharmaceutical company focused on developing and commercializing a pipeline of novel, proprietary therapeutics that have the potential to transform radiotherapy in cancer. We leverage our expertise in superoxide dismutase ...
Model GC4419 - Avasopasem Manganese

Model GC4419 - Avasopasem Manganese

Avasopasem manganese (GC4419) is an investigational selective dismutase mimetic drug in development as a radioprotector in combination with radiation therapy (RT), with the goal to reduce side effects from radiation therapy. In preclinical studies, ...
CONTACT SUPPLIER

CuraVac Europe S.A.

CuraVac Europe S.A.

based inRixensart, BELGIUM
CuraVac is a clinical-stage biotech company developing the medical and commercial potential of a revolutionary technique for the production of specific Therapeutic Vaccines for the treatment of autoimmune diseases. The company was founded by a ...
CuraVac MYASTERIX - Therapeutic Vaccine

CuraVac MYASTERIX - Therapeutic Vaccine

The MYASTERIX project (2013 – 2018) advanced a Therapeutic Vaccine candidate (designated orphan drug) indicated for myasthenia gravis (MG) to clinical proof of concept ...
CONTACT SUPPLIER

Dyadic International, Inc.

Dyadic International, Inc.

based inJupiter, FLORIDA (USA)
Dyadic International, Inc. (NASDAQ: DYAI) is a global biotechnology company focused on building innovative microbial platforms to address the growing demand for global protein bioproduction and unmet clinical needs for effective, affordable, and ...
Human Health

Human Health

We are building an active pipeline of products for human health by applying our proprietary and patented C1 technology to develop vaccines and antibodies for infectious and other diseases. Vaccine Development: The C1 platform is ready for full ...
CONTACT SUPPLIER

SYnAbs S.A.

SYnAbs S.A.

based inGosselies, BELGIUM
SYnAbs was founded in 2015 as a Belgian spin-off of the Catholic University of Louvain (UCL), based on the work of Prof. Hervé Bazin, the inventor of the world's first rat myeloma cell line. SYnAbs' vision is to fill the gap on the marketplace for ...
SYnAbs Rat-LOU Monoclonal Antibodies

SYnAbs Rat-LOU Monoclonal Antibodies

When you perform intraperitoneal injection of hapten or highly homologous antigens in mouse species, most of the time your project is going to fail. Due to poor immunogenic properties and low molecular weight, your antigen is going to be eliminated ...
CONTACT SUPPLIER

Scancell

Scancell

based inOxford, UNITED KINGDOM
Scancell is a clinical stage biopharmaceutical company that is leveraging its proprietary research, built up over many years of studying the human adaptive immune system, to generate truly novel medicines to treat significant unmet needs in cancer ...
ImmunoBody - Model SCIB1 & iSCIB1+ - Cancer Vaccines

ImmunoBody - Model SCIB1 & iSCIB1+ - Cancer Vaccines

Scancell’s lead ImmunoBody cancer vaccine, SCIB1, is being developed for the treatment of patients with metastatic melanoma. SCIB1 incorporates specific epitopes from the proteins gp100 and TRP-2, which were identified from the cloning of T ...
CONTACT SUPPLIER

OSE Immunotherapeutics

OSE Immunotherapeutics

based inNantes, FRANCE
OSE Immunotherapeutics is an integrated biotechnology company focused on developing and partnering therapies to control the immune system for immuno-oncology and autoimmune diseases. Based in Nantes (Head Office) and Paris, OSE Immunotherapeutics ...
Tedopi - Neo-Epitope-Based Vaccine

Tedopi - Neo-Epitope-Based Vaccine

Tedopi®, OSE Immunotherapeutics’s most advanced product and therapeutic neo-epitope-based vaccine, is a proprietary combination of nine optimized neo-epitopes, selected and optimized from 5 tumoral antigens to activate specifically T ...
CONTACT SUPPLIER

Scinogy Pty Ltd

Scinogy Pty Ltd

based inVictoria, AUSTRALIA
The Scinogy team is dedicated to making your clinical results a commercial reality. Provide optimized solutions for the development and manufacture of high quality, affordable cell therapies. Choosing manufacturing technologies and a scale-up ...
CONTACT SUPPLIER

Atmo Biosciences

Atmo Biosciences

based inBox Hill, AUSTRALIA
The Atmo Gas Capsule is a world-first patented solution to accurately profile the gases within the gut, leading to better diagnosis and treatment of gastrointestinal disorders. The gas-sensing capsule, when swallowed, can electronically report ...
Atmo - Gastrointestinal Gas-Sensing Capsule

Atmo - Gastrointestinal Gas-Sensing Capsule

A safe and accurate way of measuring the concentration of various gases at the source of production in the gastrointestinal tract (GI tract) in ...
CONTACT SUPPLIER

Lyophilization Technology, Inc.

Lyophilization Technology, Inc.

based inWarminster (Ivyland), PENNSYLVANIA (USA)
Lyophilization Technology, Inc. (LTI) is a Contract Development & Manufacturing Organization (CDMO) focused on all aspects of lyophilization for preparation of health care products. To the benefit of our clients, LTI has provided Development and ...
CONTACT SUPPLIER

BlueWillow Biologics

BlueWillow Biologics

based inAnn Arbor, MICHIGAN (USA)
BlueWillow Biologics is a clinical-stage, privately-held biopharmaceutical company focused on developing and commercializing intranasal vaccines using its patented nanoemulsion platform. The platform, originally discovered at the University of ...
NanoVax - Adjuvant Technology

NanoVax - Adjuvant Technology

BlueWillow’s vaccine technology incorporates nano-scale droplets that are manufactured at an average size of 400–500 nanometers to deliver and adjuvant a broad spectrum of ...
CONTACT SUPPLIER

ViCardia Therapeutics, Inc.

ViCardia Therapeutics, Inc.

based inSan Francisco, CALIFORNIA (USA)
ViCardia Therapeutics, Inc., a Delaware corporation, founded in 2017, is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel therapies for treating heart failure (HF) involving ...
CONTACT SUPPLIER

Destiny Pharma plc

Destiny Pharma plc

based inBrighton, UNITED KINGDOM
Destiny Pharma is a clinical phase biotechnology company dedicated to the development of novel anti-infectives with a focus on infection prevention. We have two exciting late-stage clinical assets and a range of earlier research programmes. Our ...
Destiny Pharma - Model NTCD-M3 - Clostridioides Difficile Programme

Destiny Pharma - Model NTCD-M3 - Clostridioides Difficile Programme

Background to the NTCD-M3 Clostridioides difficile Programme. NTCD-M3 was developed by GI infection physician, Professor Dale Gerding, who is a world-leading specialist in C. difficile, with more than 400 peer-reviewed journal publications, book ...
CONTACT SUPPLIER

OncoQR ML GmbH

OncoQR ML GmbH

based inBreitenfurt, AUSTRIA
Privately held OncoQR ML, based in Vienna/Austria, is a pre-clinical biotech company that offers novel therapeutic cancer vaccines based on its unique, proprietary and broadly applicable S-TIR™ (Specific Total Immune Remodulation) technology ...
Model OQR100/TYG100 - Active Checkpoint Control Immunotherapy (ACCI)

Model OQR100/TYG100 - Active Checkpoint Control Immunotherapy (ACCI)

Lead candidate TYG100 (formerly OQR100, out-licensed to TYG oncology Ltd.) is an “Active Checkpoint Control Immunotherapy (ACCI)” for the treatment of gastroenterological cancers such as pancreatic, stomach, colon, and gastro-esophageal ...
CONTACT SUPPLIER

Targazyme, Inc.

Targazyme, Inc.

based inCarlsbad, CALIFORNIA (USA)
TargaZyme is a clinical-stage biotechnology company based in San Diego, CA and focused on the research and development of disruptive and novel, off-the-shelf T-Cell products that are aimed at improving the efficacy of T-cell therapies by delivering ...
CONTACT SUPPLIER

MorphoSys AG

MorphoSys AG

based inPlanegg, GERMANY
MorphoSys is a commercial-stage biopharmaceutical company dedicated to the discovery, development, and delivery of innovative cancer medicines. At MorphoSys, our ambition is to redefine how cancer is treated. As a commercial-stage biopharmaceutical ...
Pelabresib - Model CPI-0610 - Investigational Selective Small-Molecule

Pelabresib - Model CPI-0610 - Investigational Selective Small-Molecule

Constellation Pharmaceuticals, a MorphoSys company, is using a starting dose of 125 mg in MANIFEST, our global, multicenter, open-label Phase 2 study of pelabresib in patients with Myelofibrosis (MF). Preclinical studies and ...
CONTACT SUPPLIER
  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical Equipment & Supplies
  • Medical Software
  • Medical Training Courses
  • Medical Industry Services
  • Medical Product Applications

Latest

  • Medical Industry News
  • Medical Industry Events

Publications

  • Medical Industry Articles & Case Studies
  • Medical Industry Books and Publications
  • Medical Industry Journals and Magazines
  • Medical Industry Downloads
  • Medical Industry Videos

Companies

  • Medical Industry Suppliers & Manufacturers

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT